SC 13G: Denali Therapeutics Inc.
Ticker: DNLI · Form: SC 13G · Filed: Aug 16, 2024 · CIK: 1714899
| Field | Detail |
|---|---|
| Company | Denali Therapeutics Inc. (DNLI) |
| Form Type | SC 13G |
| Filed Date | Aug 16, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Denali Therapeutics Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Denali Therapeutics Inc. (ticker: DNLI) to the SEC on Aug 16, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on August 16, 2024 regarding Denali Therapeutics Inc. (DNLI).